EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.4.2.3 | Acidosis |
14506 |
Impaired renal H+ secretion and NH3 production in mineralocorticoid-deficient glucocorticoid-replete dogs. |
therapeutic application
unassigned |
1
0 |
| 2.4.2.3 | Acidosis |
2081516 |
Renal tubular acidosis. |
unassigned |
0 |
| 2.4.2.3 | Adenocarcinoma |
2138895 |
Differential effects of 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2'-deoxyuridine. |
ongoing research
therapeutic application
unassigned |
2
4
0 |
| 2.4.2.3 | Adenocarcinoma |
7744869 |
Purification, cloning, and expression of murine uridine phosphorylase. |
diagnostic usage
ongoing research
unassigned |
3
3
0 |
| 2.4.2.3 | Anemia |
7562916 |
Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils. |
therapeutic application
unassigned |
2
0 |
| 2.4.2.3 | Breast Neoplasms |
11401323 |
Fluoropyrimidine sensitivity of human MCF-7 breast cancer cells stably transfected with human uridine phosphorylase. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
3
4
0 |
| 2.4.2.3 | Breast Neoplasms |
11559567 |
p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction. |
ongoing research
unassigned |
4
0 |
| 2.4.2.3 | Breast Neoplasms |
11807789 |
Expression of uridine and thymidine phosphorylase genes in human breast carcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
4
4
0 |
| 2.4.2.3 | Breast Neoplasms |
11956089 |
Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines. |
causal interaction
ongoing research
unassigned |
2
2
0 |
| 2.4.2.3 | Breast Neoplasms |
16397116 |
Modulation of uridine phosphorylase gene expression by tumor necrosis factor-alpha enhances the antiproliferative activity of the capecitabine intermediate 5'-deoxy-5-fluorouridine in breast cancer cells. |
causal interaction
ongoing research
unassigned |
4
4
0 |
